Shares of Lam Research Corp. LRCX advanced 1.09% to $71.67 Wednesday, on what proved to be an all-around great trading ...

Stifel Financial Corp dialed up its commitment to Lam Research in a move so bold it might’ve short-circuited calculators.

NEW YORK (Reuters) -Gilead Sciences has reached a $202 million settlement to resolve a civil fraud lawsuit accusing the ...

Lam Research Corporation LRCX recently posted strong third-quarter fiscal 2025 results, helping its shares rise 7% since the ...

She visited Fann hospital in Dakar, where neurologist Dr. Pedro Rodriguez measured her lung capacity. He suspects Mariama had ...

As the opioid crisis continues, the number of babies born with neonatal opioid withdrawal syndrome (NOWS) – a condition that affects infants whose mothers used opioids during pregnancy – has risen ...

JPMorgan analyst Harlan Sur lowered the firm’s price target on Lam Research (LRCX) to $95 from $110 and keeps an Overweight rating on the ...

Raymond James lowered the firm’s price target on Lam Research (LRCX) to $90 from $100 and keeps an Outperform rating on the shares. Lam ...

Chip-making equipment supplier Lam Research beat Wall Street expectations for third-quarter revenue on Wednesday, fueled by ...

Malaria is a mosquito-borne disease that is caused by Plasmodium parasites. Patients with malaria experience flu-like symptoms and, in severe cases, the disease can progress to neurological ...

"The U.S. Administration has declared it will consider responsive actions like tariffs to combat certain foreign government ...

The stock's rise snapped a three-day losing streak.